<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570179</url>
  </required_header>
  <id_info>
    <org_study_id>2011-005504-14</org_study_id>
    <nct_id>NCT01570179</nct_id>
  </id_info>
  <brief_title>Sugammadex-dosing in Bariatric Patients</brief_title>
  <acronym>SugReBaCh-1</acronym>
  <official_title>Sugammadex in Patients Undergoing Bariatric Surgery: An Equivalence Trial Comparing Real and Ideal Body Weight-based Dosing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Should the dose of sugammadex in morbid obese patients be calculated on the real body weight
      or the ideal body weight?

      The main objective of the trial is to compare in patients undergoing bariatric surgery the
      efficacy of sugammadex to obtain a TOF-ratio of 100% within 3 min when dosing is based on
      real body weight (control intervention) with dosing based on ideal body weight (experimental
      intervention). The research hypothesis is that both dosing regimens are equivalent

      The secondary objective of the trial is to compare the impact of the depth of neuromuscular
      blockade on the surgical conditions: deep block (TOF-count 1 - 3) will be compared with very
      deep block (TOF count = 0 and PTC &lt; 5)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>100% TOF-recovery 3 min after sugammadex</measure>
    <time_frame>3 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>impact of depth of block on surgical conditions</measure>
    <time_frame>every 15 min during surgery</time_frame>
    <description>to evaluate the impact of neuromuscular blockade on surgical conditions, the The &quot;King Score&quot; (King M, Anesthesiology 2000; 93:1392 - 7) will be applied every 15 min throught surgery by the surgeon (blinded to the study protocol)King-Score: from 1 to 4 with 1 excellent conditions, 2 good conditions, 3 acceptable conditions and 4 poor conditions.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>deep block ideal body weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>deep block real body weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate block ideal body weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate block real body weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ideal BW based sugammadex reversal of moderate block</intervention_name>
    <description>2 mg/kg sugammadex (based og ideal body weight)</description>
    <arm_group_label>moderate block ideal body weight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>real body weight based sugammadex reversal of moderate block</intervention_name>
    <description>2 mg/kg sugammadex (based on real BW)</description>
    <arm_group_label>moderate block real body weight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>real body weight based sugammadex reversal of deep block</intervention_name>
    <description>4 mg/kg sugammadex (based on real BW)</description>
    <arm_group_label>deep block real body weight</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ideal body weight based sugammadex reversal of deep block</intervention_name>
    <description>4 mg/kg sugammadex (based on ideal BW)</description>
    <arm_group_label>deep block ideal body weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        adult patients undergoing bariatric surgery according to the respective criteria of the
        French Medical Authority (HAS) and having given their written informed consent after
        appropriate information

        Exclusion Criteria:

        not fulfilling the inclusion criteria, known or suspected allergy to any of the drugs used
        in that study, absence of written informed consent,doubt of pregnancy in women of
        childbearing age, pregnancy and breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Strasbourg HÃ´pital Civil</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nancy</name>
      <address>
        <city>Vandoeuvre-Les-Nancy</city>
        <state>Lorraine</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2012</study_first_submitted>
  <study_first_submitted_qc>April 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>residual paralysis</keyword>
  <keyword>surgical conditions</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

